West Virginia Board Of Pharmacy Adopts New Inspection Rule: What Pharmacies Need To Know Before July 1, 2026

The West Virginia Board of Pharmacy (Board) has adopted a new legislative rule governing pharmacy inspections across the state. Effective July 1, 2026, the regulation establishes a standardized inspection framework that will impact virtually every facility regulated by the Board, including community pharmacies, institutional pharmacies, compounding pharmacies, wholesale drug distributors, manufacturers and permit holders.

While inspections are nothing new, the rule represents a significant shift toward greater consistency, documentation, accountability and public transparency in the Board’s inspection process.

For pharmacies operating in West Virginia, now is the time to review compliance programs and prepare for the new inspection requirements.

A More Structured Inspection Process

The rule formally establishes qualifications and procedures for Board inspectors. Inspectors must be licensed West Virginia pharmacists with at least ten years of pharmacy practice experience and must complete Board-approved training.

The Board will divide the state into inspection regions, with inspectors assigned to specific geographic areas. This approach is intended to promote consistency in inspection practices and oversight.

Notably, the rule requires facilities to receive at least one week’s advance notice before a scheduled inspection. However, pharmacies should not interpret this as eliminating the possibility of surprise inspections. The Board is authorized to conduct unannounced inspections annually, with such inspections limited to no more than ten percent of facilities within an inspector’s assigned region.

Increased Documentation and Compliance Tracking

One of the most consequential aspects of the new rule is the emphasis on documentation and corrective action monitoring.

Under the regulation, inspectors must follow Board-established procedures that include:

• Presenting credentials upon arrival;
• Utilizing Board-approved inspection forms;
• Reviewing specified records and documentation;
• Conducting interviews with designated personnel; and
• Documenting inspection findings in a centralized database.

Completed inspections must be entered into the Board’s database, and pharmacies will receive copies of completed inspection reports. When deficiencies are identified, inspectors must generate non-compliance reports that are tracked through a formal corrective action process.

Facilities that fail to adequately address identified deficiencies may ultimately be referred to the Board’s Complaint Committee for further review.

This enhanced tracking mechanism suggests that the Board intends to move beyond a simple inspection model and toward a more robust compliance-monitoring framework.

Publicly Available Inspection Forms

Another noteworthy development is the Board’s requirement that facility-specific inspection forms be made publicly available.

The forms must include citations to applicable statutes and Board rules and will be posted on the Board’s website.

For pharmacy operators, this provides a valuable opportunity to conduct internal audits using the same criteria likely to be applied during official inspections. Compliance officers, pharmacy managers and owners should consider incorporating these forms into their routine quality assurance and regulatory compliance programs.

Inspection Frequency by Facility Type

The rule also establishes inspection schedules for various categories of Board-regulated entities.

Annual inspections will apply to several facility types, including:

• Outpatient pharmacies;
• Institutional pharmacies;
• Charitable clinic pharmacies;
• Nuclear pharmacies;
• Sterile compounding pharmacies;
• Non-sterile compounding pharmacies;
• Wholesale drug distributors; and
• Drug manufacturers.

Facilities that maintain only a controlled substance permit and do not hold any additional Board license or permit will generally be inspected on a biennial basis.

Because inspection frequency is now clearly articulated in regulation, facilities should expect greater predictability regarding when inspections may occur.

Why This Matters

Many pharmacy boards nationwide have increased their focus on inspection consistency, documentation and enforcement over the past several years. West Virginia’s new rule reflects that broader trend.

The regulation creates clearer expectations for both inspectors and regulated entities while giving the Board additional tools to monitor corrective actions and identify repeat compliance concerns.

For pharmacies, wholesalers, manufacturers and compounding facilities, preparation should begin well before the July 1 effective date. Organizations should review policies and procedures, conduct mock inspections, verify recordkeeping practices and ensure that staff understand how inspections will be conducted under the new framework.

Facilities that proactively evaluate compliance now will be better positioned to navigate future inspections and reduce regulatory risk.

Looking Ahead

The West Virginia Board of Pharmacy’s new inspection rule represents one of the more comprehensive efforts in recent years to standardize inspection practices across regulated pharmacy facilities. While many of the underlying compliance expectations remain familiar, the increased emphasis on documentation, corrective action tracking and transparency will likely lead to heightened scrutiny of pharmacy operations.

Pharmacies and other regulated entities should take advantage of the period before implementation to review their compliance programs and prepare accordingly.

If your organization has questions regarding inspection readiness, pharmacy compliance, compounding operations, controlled substance requirements or Board of Pharmacy enforcement matters, experienced pharmacy regulatory counsel can help assess risk and develop a proactive compliance strategy.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.